» Articles » PMID: 29333310

Hemiataxia: A Novel Presentation of Anti-NMDA Receptor Antibody Mediated Encephalitis in an Adolescent

Overview
Publisher Wiley
Specialty Psychiatry
Date 2018 Jan 16
PMID 29333310
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Anti-NMDA receptor antibody associated encephalitis as a cause of new-onset neuropsychiatric manifestations in children and adults can represent a significant diagnostic challenge for clinicians. Clinical signs often include encephalopathy, new-onset psychosis, and movement phenomenon. Although orofacial dyskinesias were initially identified as a characteristic movement phenomenon in this type of encephalitis, an expanded range of abnormalities has recently been reported, including isolated ataxia. We report a case of isolated hemiataxia in a young adult with mild initial psychiatric manifestations. A personal and family history of preceding neuropsychiatric symptoms produced diagnostic confusion and resulted in a significant diagnostic and therapeutic delay. Our case confirms the unilateral movement manifestations that have been emphasized in recent reports. Additionally, it confirms the need for involvement of neurologic as well as psychiatric services in the evaluation of such cases and emphasizes the importance of the neurologic examination in presentations with an initial psychiatric predominance.

Citing Articles

Anti-NMDA receptor encephalitis after yellow fever vaccination: a case report.

Coeckelbergh E, Reynders T Acta Neurol Belg. 2021; 121(5):1357-1359.

PMID: 33963528 DOI: 10.1007/s13760-021-01673-7.

References
1.
Steinlechner S, Hagenah J, Rumpf H, Meyer C, John U, Baumer T . Associations of specific psychiatric disorders with isolated focal dystonia, and monogenic and idiopathic Parkinson's disease. J Neurol. 2017; 264(6):1076-1084. DOI: 10.1007/s00415-017-8488-x. View

2.
Herken J, Pruss H . Red Flags: Clinical Signs for Identifying Autoimmune Encephalitis in Psychiatric Patients. Front Psychiatry. 2017; 8:25. PMC: 5311041. DOI: 10.3389/fpsyt.2017.00025. View

3.
Titulaer M, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T . Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12(2):157-65. PMC: 3563251. DOI: 10.1016/S1474-4422(12)70310-1. View

4.
Finke C, Kopp U, Pruss H, Dalmau J, Wandinger K, Ploner C . Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2011; 83(2):195-8. PMC: 3718487. DOI: 10.1136/jnnp-2011-300411. View

5.
Yeshokumar A, Sun L, Klein J, Baranano K, Pardo C . Gait Disturbance as the Presenting Symptom in Young Children With Anti-NMDA Receptor Encephalitis. Pediatrics. 2016; 138(3). DOI: 10.1542/peds.2016-0901. View